We serve Chemical Name:acetaldehyde,azane CAS:75-39-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:acetaldehyde,azane
CAS.NO:75-39-8
Synonyms:1-aminoethanol;acetaldehyde ammonia;monoaminoethanol;Ethanol,1-amino;EINECS 200-868-2;aminoethanol;Ethanol,1-amino-(8CI,9CI);MFCD00008058
Molecular Formula:C2H5NO
Molecular Weight:59.06720
HS Code:
Physical and Chemical Properties:
Melting point:95-97°C (dec.)
Boiling point:109-111°C
Density:0.967g/cm3
Index of Refraction:1.431
PSA:43.09000
Exact Mass:59.03710
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:1841
Packing Group:III
Contact us for information like 1-aminoethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00008058 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethanol,1-amino Use and application,aminoethanol technical grade,usp/ep/jp grade.
Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. acetaldehyde,azane manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). acetaldehyde,azane supplier On Friday, the US Association of Flight Attendants — which represents 50,000 flight attendants across 20 airlines — called on the government to work with airlines to discontinue all travel to China until the spread of coronavirus is contained. acetaldehyde,azane vendor On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks. acetaldehyde,azane factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).
